Outcomes of CPM Usage Following Arthroscopic Acetabular Labral Repair
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03407612|
Recruitment Status : Completed
First Posted : January 23, 2018
Results First Posted : August 2, 2018
Last Update Posted : August 2, 2018
|Condition or disease||Intervention/treatment||Phase|
|Femoro Acetabular Impingement Pain, Postoperative Hip Labral Tear||Device: Continuous Passive Motion||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||54 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||The Effect of Continuous Passive Motion on Pain Control Following Hip Arthroscopy|
|Actual Study Start Date :||February 15, 2013|
|Actual Primary Completion Date :||June 25, 2015|
|Actual Study Completion Date :||June 25, 2015|
Active Comparator: CPM
These subjects received a continuous passive motion (CPM) device and were instructed to use it for 4-6 hours daily throughout the first two postoperative weeks following their arthroscopic labral repair. They were provided adequate education on how to operate the device. The subjects recorded their average usage of the CPM, as well as their personal perception of the CPM, at the postoperative 2 day, 7 day, and 14 day marks.
Device: Continuous Passive Motion
CPM devices are used in postoperative rehabilitation and are throughout to reduce joint stiffness.
No Intervention: No CPM
No CPM was administered to these subjects.
- Change in Patient Satisfaction and Functional Outcome [ Time Frame: Baseline and 6 weeks, 12 weeks, and 6 months postoperatively ]Hip Outcome Score Activities of Daily Living (HOS ADL) questionnaire completed at specific time points. Completion of the HOS ADL provides a score from 0 to 100, with a higher score corresponding to greater level of function. The improvement preoperative to 6 month postoperative scores was also computed.
- Analgesic Usage [ Time Frame: Initial two postoperative weeks ]Analgesic usage measured via the morphine-equivalent dose of consumed analgesic medications
- Pain Level [ Time Frame: Initial two postoperative weeks ]Change in pain level measured on a Likert-type scale from 0 to 10, with higher scores representing higher pain levels.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03407612
|United States, Ohio|
|The Ohio State University Wexner Medical Center|
|Columbus, Ohio, United States, 43212|
|Principal Investigator:||John Ryan, MD||The Ohio State University Wexner Medical Center|